Although at pre-clinical stage, the HBV program will leverage many of the features and advances from our other liver disease program, TT-034 for Hepatitis C, which is currently in Phase I/IIA human clinical trials.
http://www.benitec.com/pipeline/in-house-programs-detail
- Forums
- ASX - By Stock
- HBV
Although at pre-clinical stage, the HBV program will leverage...
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online